by Rod Raynovich | Jun 7, 2010 | 2023-24 Life Science Portfolios, BIOgraph
Two Big Winners in Bristol Myers Squibb and Celgene The American Society of Oncology Meeting is normally good times for biotech as scientific and clinical developments propel stocks. This year the personalized medicine theme with potential breakthroughs in targeted...